The LLR TAP IcICLLe trial: Assessing biological response to ibrutinib in CLL: immediate disease redistribution precedes cell cycle arrest by 2 weeks with reduced bone marrow infiltration by 6 months
Andy C Rawstron, Talha Munir, Surita Dalal, Ruth M de Tute, Kristian Brock, Christopher Fox, Donald MacDonald, Christopher Fegan, Adrian Bloor, Peter Hillmen
Research output: Contribution to conference (unpublished) › Abstract › peer-review
Fingerprint
Dive into the research topics of 'The LLR TAP IcICLLe trial: Assessing biological response to ibrutinib in CLL: immediate disease redistribution precedes cell cycle arrest by 2 weeks with reduced bone marrow infiltration by 6 months'. Together they form a unique fingerprint.